Walleye Trading’s SBC Medical Group SBC Stock Holding History

Walleye Trading’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-48,407	Closed	-$633K	–	4675
2024 Q2	$633K	Sell	48,407 -22,081	-31%	-$296K	﹤0.01%	2367
2024 Q1	$895K	Sell	70,488 -10,548	-13%	-$121K	﹤0.01%	2338
2023 Q4	$873K	Hold	81,036	–	–	﹤0.01%	2594
2023 Q3	$865K	Hold	81,036	–	–	﹤0.01%	2490
2023 Q2	$834K	Buy	+81,036	New	+$837K	﹤0.01%	2344

Other funds holding SBC

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Walleye Trading's SBC Position: Q3 2024 in Review

Walleye Trading sold out of SBC Medical Group (SBC) in Q3 2024, closing a stake of 48,407 shares — an estimated $633K sold.

Walleye Trading first reported a position in SBC in Q2 2023 and held it in 5 quarters. The position peaked at $895K in Q1 2024. 3 funds tracked by Wall St. Rank hold SBC as of Q3 2024.

Walleye Trading reported no remaining SBC Medical Group position as of Q3 2024 after selling out during the quarter.
Walleye Trading sold 48,407 SBC Medical Group shares in Q3 2024, an estimated $633K.
Walleye Trading first reported a position in SBC Medical Group in Q2 2023 and held it in 5 quarters.
Walleye Trading's SBC Medical Group position peaked at $895K in Q1 2024.
3 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.